RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- 1 July 2020
- journal article
- retracted article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 56 (1) , 105949
- https://doi.org/10.1016/j.ijantimicag.2020.105949
Abstract
No abstract availableKeywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat themCurrent Opinion in Infectious Diseases, 2018
- Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple’s diseaseJournal of Chromatography B, 2017
- Zika virus cell tropism in the developing human brain and inhibition by azithromycinProceedings of the National Academy of Sciences, 2016
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology, 2016
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such IllnessesJAMA, 2015
- Evaluation of Ebola Virus Inhibitors for Drug RepurposingACS Infectious Diseases, 2015
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal modelProceedings of the National Academy of Sciences, 2008
- Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral ActivitiesJournal of Medicinal Chemistry, 2006
- Treatment of Q Fever EndocarditisArchives of internal medicine (1960), 1999